Senolytic Drug Interactions: What You Must Know Before Starting

Expert Summary

Senolytic drug interactions fall into two categories: (1) natural senolytic interactions (fisetin, quercetin) — generally mild and primarily relevant for anticoagulant and narrow-therapeutic-index drugs, and (2) pharmaceutical senolytic interactions (dasatinib) — clinically significant for CYP3A4 substrates and QT-prolonging drugs, requiring physician management.

Key Facts

• Anticoagulant interaction (fisetin, quercetin): Both have mild antiplatelet effects via thromboxane B2 inhibition and platelet aggregation inhibition. In patients on warfarin, heparin, clopidogrel, or aspirin, additive antiplatelet/anticoagulant effects increase bleeding risk. Monitor INR more frequently if combining with warfarin. Discuss with prescribing physician.
• CYP3A4 inhibition (fisetin, quercetin): Both mildly inhibit CYP3A4 at high concentrations. For most CYP3A4-metabolized drugs (statins, some antiepileptics, immunosuppressants), senolytic supplement doses are unlikely to cause clinically significant interactions. Exception: drugs with very narrow therapeutic windows (cyclosporine, tacrolimus) — use with caution.
• Thyroid interaction (quercetin): High-dose quercetin has theoretical anti-thyroid activity (inhibiting thyroid peroxidase). Patients on thyroid hormone replacement should monitor thyroid function after starting quercetin.
• Dasatinib CYP3A4 interactions: Dasatinib is a CYP3A4 substrate AND inhibitor. Strong CYP3A4 inhibitors (grapefruit, ketoconazole, ritonavir) increase dasatinib plasma levels and side effects. Strong CYP3A4 inducers (rifampin, carbamazepine, St. John's Wort) reduce dasatinib efficacy.
• Dasatinib QT prolongation: Dasatinib prolongs QTc interval. Avoid combining with other QT-prolonging drugs: quinolone antibiotics, azithromycin, antipsychotics, certain antihistamines. Baseline ECG essential.
• Dasatinib + metformin: OCT2 transporter competition may slightly increase metformin levels. Monitor for GI symptoms. Quercetin at supplement doses also competes at OCT2 but the interaction is mild.

Recommended Products

Frequently Asked Questions

I take a statin. Can I use senolytic supplements?

Yes, in most cases. Fisetin and quercetin at supplement doses are unlikely to significantly affect statin metabolism. Simvastatin and lovastatin (most CYP3A4-dependent statins) have the most theoretical interaction risk; pravastatin and rosuvastatin are not CYP3A4-metabolized and are safer to combine.

Should I stop quercetin 1 week before surgery?

Given quercetin's mild antiplatelet effects, stopping 7–10 days before elective surgery is a reasonable precaution, consistent with general guidance for supplements with antiplatelet activity.

Scientific References

• Boots AW et al. Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology. 2008. PMID: 18417116